For the year ending 2025-12-31, LONA has $92,151K in assets. $64,361K in debts. $69,276K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 69,276 | |||
| Short-term investments | 19,055 | |||
| Prepaid expenses and other current assets | 1,127 | |||
| Total current assets | 89,458 | |||
| Restricted cash | 631 | |||
| Property and equipment, at cost | 5,739 | |||
| Less accumulated depreciation | 4,267 | |||
| Property and equipment, net | 1,472 | |||
| Operating lease right-of-use asset | 535 | |||
| Other long-term assets | 55 | |||
| Total assets | 92,151 | |||
| Accounts payable | 4,587 | |||
| Accrued liabilities | 4,963 | |||
| Sermonix pre-funded warrant | 37,488 | |||
| Current operating lease liability | 465 | |||
| Total current liabilities | 47,503 | |||
| Operating lease liability, less current portion | 338 | |||
| Milestone liabilities | 15,116 | |||
| Other long-term liabilities | 1,404 | |||
| Total liabilities | 64,361 | |||
| Common stock, 0.0001 par value 90,000,000 shares authorized at december 31, 2025 and december 31, 2024, respectively 9,335,913 and 3,904,049 shares issued and outstanding at december 31,2025 and december 31,2024, respectively | 1 | |||
| Additional paid-in capital | 539,548 | |||
| Accumulated other comprehensive (loss) income | -4 | |||
| Accumulated deficit | -511,755 | |||
| Total stockholders' equity | 27,790 | |||
| Total liabilities and stockholders' equity | 92,151 | |||
LeonaBio, Inc. (LONA)
LeonaBio, Inc. (LONA)